Press Releases NetraMark Holdings Inc.

Equities

AIAI

CA64119M1059

Market Closed - Canadian Securities Exchange Other stock markets 01:22:40 11/05/2024 am IST			5-day change	1st Jan Change
0.305 ^CAD	-6.15%		-4.69%	-12.86%

10/04	Netramark's Ai-Based Clinical Solution Identifies Novel Lung and Colon Cancer Biomarkers and Patient Subpopulations	CI
04/04	NetraMark Holdings Inc. announces appointment of Jeff Huntsman to its strategic advisory board	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NETRAMARK'S AI-BASED CLINICAL SOLUTION IDENTIFIES NOVEL LUNG AND COLON CANCER BIOMARKERS AND PATIENT SUBPOPULATIONS	10/04	AQ
NETRAMARK ANNOUNCES SHAREHOLDER MEETING RESULTS	05/04	AQ
PHARMACEUTICAL INDUSTRY VETERAN JOINS NETRAMARK ADVISORY BOARD	04/04	AQ
NETRAMARK PROVIDES BUSINESS UPDATE AND HIGHLIGHTS PROGRESS	02/04	AQ
NETRAMARK SIGNS CONTRACT WITH PHARMACEUTICAL COMPANY TO DELIVER CLINICAL TRIAL INSIGHTS REGARDING EFFICACY AND PLACEBO RESPONSE	12/03	AQ
NETRAMARK'S AI-BASED CLINICAL SOLUTION IDENTIFIES PARKINSON'S DISEASE SUBTYPES LINKED BY MITOCHONDRIAL, MICROBIOME AND IMMUNE SIGNALING	11/03	AQ
NETRAMARK TO PRESENT NEW DATA HIGHLIGHTING THE UTILITY OF IT'S AI-BASED CLINICAL SOLUTION IN IDENTIFYING PARKINSON'S DISEASE ASSOCIATED BIOMARKERS AT AD/PD™ 2024	29/02	AQ
NETRAMARK SIGNS FOURTH CONTRACT WITH LARGE BIOPHARMACEUTICAL COMPANY TO ENHANCE CLINICAL TRIAL INSIGHTS	27/02	AQ
NETRAMARK'S AI-BASED TECHNOLOGY IDENTIFIES SIGNIFICANT DRIVERS OF EFFICACY AND PLACEBO RESPONSES AND HAS POTENTIAL TO IMPROVE SUCCESS RATES FOR CLINICAL TRIALS OF PSYCHIATRIC MEDICATIONS	26/02	AQ
NETRAMARK TO PRESENT NEW DATA DEMONSTRATING THE POWER OF ITS AI BASED TECHNOLOGY TO DE-RISK NEUROLOGY CLINICAL TRIALS AT ISCTM ANNUAL MEETING	15/02	AQ
NETRAMARK ANNOUNCES LAUNCH OF THE NETRA AI LAB	12/02	AQ
NETRAMARK SIGNS THIRD CONTRACT WITH LARGE BIOPHARMACEUTICAL COMPANY TO ENHANCE CLINICAL TRIAL INSIGHTS	30/01	AQ
NetraMark's Generative AI Discovers Novel Rare Disease Drug Targets and Unique Patient Subpopulations That Could Substantially Improve Clinical Trial Success Rates	16/01	AQ
NETRAMARK SIGNS TWO CONTRACTS WITH LARGE BIOPHARMACEUTICAL COMPANY TO ENHANCE CLINICAL TRIAL INSIGHTS	20/12	AQ
NETRAMARK SELECTS FINN PARTNERS AS ITS PUBLIC RELATIONS AGENCY OF RECORD	20/11	AQ
PHARMACEUTICAL INDUSTRY VETERAN JOINS NETRAMARK AS CHIEF MEDICAL OFFICER	06/11	AQ
NETRAMARK SIGNS MASTER SERVICE AGREEMENT WITH A LARGE BIOPHARMACEUTICAL COMPANY	31/23/31	AQ
NETRAMARK CLOSES PRIVATE PLACEMENT FINANCING	20/23/20	AQ
NETRAMARK PRIVATE PLACEMENT - PRESS RELEASE CLARIFICATION	16/23/16	AQ
NETRAMARK ANNOUNCES PRIVATE PLACEMENT FINANCING	12/23/12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases NetraMark Holdings Inc.

Equities

AIAI

CA64119M1059

Press Releases

Filters